サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1454118

組換え抗体市場：タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年

Recombinant Antibodies Market, By Type, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 290 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
組換え抗体市場：タイプ別、用途別、国別、地域別 - 産業分析、市場規模、市場シェア、予測、2024-2032年
出版日: 2024年03月15日
発行: AnalystView Market Insights
ページ情報: 英文 290 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

組換え抗体市場規模は2023年に121億1,000万米ドルとなり、2024年から2032年にかけてCAGR 6.5%で拡大

組換え抗体市場-市場力学

がんと感染症患者の増加が市場成長を牽引

予測期間中、組換え抗体市場は、世界の感染症やがんの罹患率の上昇に伴って成長すると予測されます。組換え抗体は、がん細胞表面に発現する抗原を同定して結合させることで、がん化した細胞を正確に標的にするように設計されています。従来の化学療法に比べ、この集中的なアプローチは副作用を減らし、健康な細胞への害を減少させる。これはまた、感染性病原体に対する即時防御を提供する受動免疫にも使用できます。免疫反応に似せて作られているため、ある種のウイルス感染症の流行時など、感染症の危険にさらされている、あるいはさらされている人々に投与することができます。例えば、GLOBOCAN（Global Cancer Observatory）の推計によると、2020年には世界で1,930万人のがん患者が発生するとされています。インドは米国、中国に次いで第3位です。2040年にはインドで新たに208万人のがん症例が発見され、2020年から57.5％増加します。

組換え抗体市場-主要インサイト

弊社のリサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約6.5%のCAGRで毎年成長すると予測されています。

タイプ別セグメンテーションに基づくと、一本鎖抗体セグメントは予測期間中に最大の収益シェアを獲得する見込みです。

用途別では、製薬・バイオテクノロジー分野が予測期間で市場を独占する見込み

地域別では、北米が予測期間中に市場を独占すると予想される

組換え抗体市場-セグメンテーション分析：

組換え抗体の世界市場は、タイプ、用途、地域に基づいてセグメント化されます。

タイプに基づき、組換え抗体市場は一本鎖抗体、完全ヒト抗体、ヒト化抗体、キメラ抗体、二重特異性抗体に分類されます。一本鎖抗体セグメントは予測期間中、最大の収益シェアを獲得すると予想されています。一本鎖抗体の製造には組換えDNA技術が使用され、結合特異性や親和性の変更が可能です。この特性は、様々な病気に関連する特定の抗原に焦点を当てる際の適応性を高める。scFv分子は一般的な抗体よりもサイズが小さく構造が単純であるため、状況によっては有用です。

用途別に見ると、世界の組換え抗体市場は、病院・診断研究所、製薬・バイオテクノロジー、研究機関、その他に区分されます。予測期間中、製薬・バイオテクノロジー分野が市場を独占すると見られています。大手製薬企業やバイオテクノロジー企業は、組換え抗体に関する研究開発活動に多額の投資を行っています。したがって、このセグメントの拡大を牽引しています。

組換え抗体市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。予測期間中、北米が市場を独占すると見られています。この地域の市場拡大は、大手企業の存在に起因しています。さらに、がんやその他の感染症の有病率が上昇していることも、同地域の市場成長を大きく後押ししています。

組換え抗体市場-競合情勢：

市場に参入している主要企業は、製品上市、買収、提携、その他を含む、業界で主要な市場シェアを獲得するために様々な戦略を採用しています。

目次

第1章 組換え抗体市場概要

  • 調査範囲
  • 市場推定年数

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 組換え抗体の主要な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 今後の市場動向

第4章 組換え抗体産業の調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 組換え抗体市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 組換え抗体市場情勢

  • 組換え抗体市場シェア分析、2023年
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 組換え抗体市場- タイプ別

  • 概要
    • タイプ別のセグメントシェア分析
    • 一本鎖抗体
    • 完全ヒト抗体
    • ヒト化抗体
    • キメラ抗体
    • 二重特異性抗体

第8章 組換え抗体市場- 用途別

  • 概要
    • 用途別のセグメントシェア分析
    • 病院・診断研究所
    • 製薬・バイオテクノロジー
    • 研究機関
    • その他

第9章 組換え抗体市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋地域の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 中東とアフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第10章 主要ベンダー分析- 組換え抗体産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Bio-Rad Laboratories
    • GE Healthcare
    • F. Hoffmann-La Roche
    • BIOLEGEND
    • BD Biosciences
    • Creative Biolabs
    • Merck KGaA
    • Abnova
    • Abcam
    • SinoBiological
    • BBI Solutions
    • ProMab Biotechnologies
    • Beckman Coulter

第11章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Recombinant Antibodies Market: Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Recombinant Antibodies Market, by Type 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Recombinant Antibodies Market, by Application 2019-2032 (USD Million)
  • TABLE Recombinant Antibodies Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Recombinant Antibodies Market, by Region 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE North America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Europe Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Latin America Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Recombinant Antibodies Market, by Application, 2019-2032 (USD Million)

List of Figures

  • FIGURE Recombinant Antibodies Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Type segment market share analysis, 2023 & 2032
  • FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Application segment market share analysis, 2023 & 2032
  • FIGURE Application segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Europe Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Asia Pacific Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Latin America Recombinant Antibodies Market share and leading players, 2023
  • FIGURE Middle East and Africa Recombinant Antibodies Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Germany Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE India Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Phillipines Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Brazil Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Recombinant Antibodies Market share analysis by country, 2023
  • FIGURE Saudi Arabia Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Recombinant Antibodies Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV2299

REPORT HIGHLIGHT

Recombinant Antibodies Market size was valued at USD 12,110 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.

Synthetic monoclonal antibodies, or recombinant antibodies, are created in vitro using recombinant DNA technology as a substitute for the traditional hybridoma-based approach of manufacturing monoclonal antibodies. Recombinant antibodies may be created without vaccinating animals since synthetic genes are employed to make them outside of the immune system. These synthetic antibodies are superior to traditional animal-derived antibodies in a number of respects and may be used in any application due to their high specificity, sensitivity, and repeatability.

Recombinant Antibodies Market- Market Dynamics

Increasing cases of cancer and infectious disease drives market growth

Over the projected period, the market for recombinant antibodies is anticipated to grow as a result of the rising incidence of infectious diseases and cancer cases worldwide. By identifying and attaching to antigens expressed on the surface of cancer cells, recombinant antibodies are engineered to precisely target cells that are cancerous. Compared to conventional chemotherapy, this focused approach reduces adverse effects and decreases harm to healthy cells. This may also be used to passive immunization, which offers instant defense against infectious pathogens. They can be given to those who are at danger or have been exposed to infections, such as in the event of certain viral epidemics, since they are made to resemble the immune response. For instance, according to estimates from the Global Cancer Observatory (GLOBOCAN), there will be 19.3 million incident cases of cancer globally in 2020. India placed third, behind the United States of America and China. 2.08 million new cases of cancer would be detected in India in 2040, up 57.5 percent from 2020.

Recombinant Antibodies Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)

Based on type segmentation, the Single Chain Antibody segment is expected to capture the largest revenue share over the projected period

Based on application segmentation, the Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period

Based on region, North America is expected to dominate the market over the forecast period

Recombinant Antibodies Market- Segmentation Analysis:

The Global Recombinant Antibodies Market is segmented based on Type, Application and Region.

Based on the type, the Recombinant Antibodies market is bifurcated into Single Chain Antibody, Full Human Antibody, Humanized Antibody, Chimeric Antibody and Bispecific Antibody. The Single Chain Antibody segment is expected to capture the largest revenue share over the projected period. Recombinant DNA technology is used to manufacture single chain antibodies, enabling the modification of binding specificity and affinity. This characteristic increases their adaptability in focusing on particular antigens associated with a range of illnesses. Because of their smaller size and simpler structure than typical antibodies, scFv molecules are useful in some situations. greater tissue penetration may be made possible by their lower size, which might lead to greater therapeutic results.

Based on the application, the global Recombinant Antibodies market is segmented into Hospitals & Diagnostic Laboratories, Pharmaceutical & Biotechnology, Research Institutes and Others. The Pharmaceutical & Biotechnology segment is expected to dominate the market over the projected period. Major pharmaceutical and biotechnology companies invest heavily in research and development activities related to recombinant antibodies. Thus, driving the segment expansion.

Recombinant Antibodies Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. North America is expected to dominate the market over the forecast period. The regional market expansion is attributed to the presence of major players. Additionally, the rising prevalence of cancer and others infectious disease significantly drive the market growth in the region.

Recombinant Antibodies Market- Competitive Landscape:

The key players operating in the market are Bio-Rad Laboratories, GE Healthcare, F. Hoffmann-La Roche, BIOLEGEND, BD Biosciences, Creative Biolabs, Merck KGaA, Abnova, Abcam, SinoBiological, BBI Solutions, ProMab Biotechnologies and Beckman Coulter. These players adopted various strategies to gain major market share in the industry including product launch, acquisition, collaboration and others.

Recent Developments:

In November 2023, Lonza declared the opening of its new GS Effex(R) cell line to facilitate the production of more potent therapeutic antibodies. The GS Effex(R) cell line was created in response to urgent market demands brought on by the move toward more advanced therapeutic antibodies. GS Effex(R), which is derived from Lonza's top-performing GS Xceed(R) cell line, integrates well with Lonza platforms. When coupled with robust cell growth and the capacity to generate potent therapeutic antibodies, this unique cell line offers a solution for therapeutic development spanning from early-stage research to commercial manufacture.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL RECOMBINANT ANTIBODIES MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Bio-Rad Laboratories

GE Healthcare

F. Hoffmann-La Roche

BIOLEGEND

BD Biosciences

Creative Biolabs

Merck KGaA

Abnova

Abcam

SinoBiological

BBI Solutions

ProMab Biotechnologies

Beckman Coulter

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Single Chain Antibody
  • Full Human Antibody
  • Humanized Antibody
  • Chimeric Antibody
  • Bispecific Antibody

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Laboratories
  • Pharmaceutical & Biotechnology
  • Research Institutes
  • Others

GLOBAL RECOMBINANT ANTIBODIES MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1.Recombinant Antibodies Market Overview

  • 1.1.Study Scope
  • 1.2.Market Estimation Years

2.Executive Summary

  • 2.1.Market Snippet
    • 2.1.1.Recombinant Antibodies Market Snippet by Type
    • 2.1.2.Recombinant Antibodies Market Snippet by Application
    • 2.1.3.Recombinant Antibodies Market Snippet by Country
    • 2.1.4.Recombinant Antibodies Market Snippet by Region
  • 2.2.Competitive Insights

3.Recombinant Antibodies Key Market Trends

  • 3.1.Recombinant Antibodies Market Drivers
    • 3.1.1.Impact Analysis of Market Drivers
  • 3.2.Recombinant Antibodies Market Restraints
    • 3.2.1.Impact Analysis of Market Restraints
  • 3.3.Recombinant Antibodies Market Opportunities
  • 3.4.Recombinant Antibodies Market Future Trends

4.Recombinant Antibodies Industry Study

  • 4.1.PEST Analysis
  • 4.2.Porter's Five Forces Analysis
  • 4.3.Growth Prospect Mapping
  • 4.4.Regulatory Framework Analysis

5.Recombinant Antibodies Market: COVID-19 Impact Analysis

  • 5.1.Pre-COVID-19 Impact Analysis
  • 5.2.Post-COVID-19 Impact Analysis
    • 5.2.1.Top Performing Segments
    • 5.2.2.Marginal Growth Segments
    • 5.2.3.Top Looser Segments
    • 5.2.4.Marginal Loss Segments

6.Recombinant Antibodies Market Landscape

  • 6.1.Recombinant Antibodies Market Share Analysis, 2023
  • 6.2.Breakdown Data, by Key Manufacturer
    • 6.2.1.Established Players' Analysis
    • 6.2.2.Emerging Players' Analysis

7.Recombinant Antibodies Market - By Type

  • 7.1.Overview
    • 7.1.1.Segment Share Analysis, By Type, 2023 & 2032 (%)
    • 7.1.2.Single Chain Antibody
    • 7.1.3.Full Human Antibody
    • 7.1.4.Humanized Antibody
    • 7.1.5.Chimeric Antibody
    • 7.1.6.Bispecific Antibody

8.Recombinant Antibodies Market - By Application

  • 8.1.Overview
    • 8.1.1.Segment Share Analysis, By Application, 2023 & 2032 (%)
    • 8.1.2.Hospitals & Diagnostic Laboratories
    • 8.1.3.Pharmaceutical & Biotechnology
    • 8.1.4.Research Institutes
    • 8.1.5.Others

9.Recombinant Antibodies Market- By Geography

  • 9.1.Introduction
    • 9.1.1.Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 9.2.North America
    • 9.2.1.Overview
    • 9.2.2.Recombinant Antibodies Key Manufacturers in North America
    • 9.2.3.North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4.North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5.North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.6.U.S.
      • 9.2.6.1.Overview
      • 9.2.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3.U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4.U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.2.7.Canada
      • 9.2.7.1.Overview
      • 9.2.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3.Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4.Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.3.Europe
    • 9.3.1.Overview
    • 9.3.2.Recombinant Antibodies Key Manufacturers in Europe
    • 9.3.3.Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4.Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5.Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.6.Germany
      • 9.3.6.1.Overview
      • 9.3.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3.Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4.Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.7.Italy
      • 9.3.7.1.Overview
      • 9.3.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3.Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4.Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.8.United Kingdom
      • 9.3.8.1.Overview
      • 9.3.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3.United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4.United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.9.France
      • 9.3.9.1.Overview
      • 9.3.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3.France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4.France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.10.Russia
      • 9.3.10.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.2.Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.3.Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.11.Netherlands
      • 9.3.11.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2.Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3.Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.12.Sweden
      • 9.3.12.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2.Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3.Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.13.Poland
      • 9.3.13.1.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2.Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3.Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.3.14.Rest of Europe
      • 9.3.14.1.Overview
      • 9.3.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.3.Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.4.Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.4.Asia Pacific (APAC)
    • 9.4.1.Overview
    • 9.4.2.Recombinant Antibodies Key Manufacturers in Asia Pacific
    • 9.4.3.Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4.Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5.Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.6.India
      • 9.4.6.1.Overview
      • 9.4.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3.India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4.India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.7.China
      • 9.4.7.1.Overview
      • 9.4.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3.China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4.China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.8.Japan
      • 9.4.8.1.Overview
      • 9.4.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3.Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4.Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.9.South Korea
      • 9.4.9.1.Overview
      • 9.4.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3.South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4.South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.10.Australia
      • 9.4.10.1.Overview
      • 9.4.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3.Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4.Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.11.Thailand
      • 9.4.11.1.Overview
      • 9.4.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3.Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4.Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.12.Indonesia
      • 9.4.12.1.Overview
      • 9.4.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3.Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4.Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.13.Philippines
      • 9.4.13.1.Overview
      • 9.4.13.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3.Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4.Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.4.14.Rest of APAC
      • 9.4.14.1.Overview
      • 9.4.14.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3.Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4.Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.5.Latin America
    • 9.5.1.Overview
    • 9.5.2.Recombinant Antibodies Key Manufacturers in Latin America
    • 9.5.3.Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4.Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5.Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.6.Brazil
      • 9.5.6.1.Overview
      • 9.5.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3.Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4.Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.7.Mexico
      • 9.5.7.1.Overview
      • 9.5.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3.Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4.Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.8.Argentina
      • 9.5.8.1.Overview
      • 9.5.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3.Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4.Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.9.Colombia
      • 9.5.9.1.Overview
      • 9.5.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3.Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4.Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.5.10.Rest of LATAM
      • 9.5.10.1.Overview
      • 9.5.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3.Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4.Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
  • 9.6.Middle East and Africa
    • 9.6.1.Overview
    • 9.6.2.Recombinant Antibodies Key Manufacturers in Middle East and Africa
    • 9.6.3.Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4.Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5.Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.6.Saudi Arabia
      • 9.6.6.1.Overview
      • 9.6.6.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3.Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4.Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.7.United Arab Emirates
      • 9.6.7.1.Overview
      • 9.6.7.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3.United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4.United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.8.Israel
      • 9.6.8.1.Overview
      • 9.6.8.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3.Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4.Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.9.Turkey
      • 9.6.9.1.Overview
      • 9.6.9.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3.Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4.Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.10.Algeria
      • 9.6.10.1.Overview
      • 9.6.10.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3.Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4.Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.11.Egypt
      • 9.6.11.1.Overview
      • 9.6.11.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3.Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4.Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 9.6.12.Rest of MEA
      • 9.6.12.1.Overview
      • 9.6.12.2.Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3.Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4.Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

10.Key Vendor Analysis- Recombinant Antibodies Industry

  • 10.1.Competitive Dashboard
  • 10.2.Company Profiles
    • 10.2.1.Bio-Rad Laboratories
    • 10.2.2.GE Healthcare
    • 10.2.3.F. Hoffmann-La Roche
    • 10.2.4.BIOLEGEND
    • 10.2.5.BD Biosciences
    • 10.2.6.Creative Biolabs
    • 10.2.7.Merck KGaA
    • 10.2.8.Abnova
    • 10.2.9.Abcam
    • 10.2.10.SinoBiological
    • 10.2.11.BBI Solutions
    • 10.2.12.ProMab Biotechnologies
    • 10.2.13.Beckman Coulter

11.360 Degree Analyst View

12.Appendix

  • 12.1.Research Methodology
  • 12.2.References
  • 12.3.Abbreviations
  • 12.4.Disclaimer
  • 12.5.Contact Us